Concomitant use may increase the risk of gastrointestinal bleeding.
Increased risk of gastrointestinal bleeding when SSRIs are taken with NSAIDs.
Monitor patients for signs of GI bleeding, such as black stool or severe abdominal pain.
Consider alternatives or protective measures if both drugs are necessary.
Dosage adjustments may be required.
Selective Serotonin Reuptake Inhibitors (SSRIs) can inhibit platelet aggregation due to their effect on serotonin receptors in platelets. Concurrent use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which also affect platelet function, can further compromise hemostasis and elevate the risk of gastrointestinal hemorrhage. SSRIs alter serotonin levels, which play a role in maintaining mucosal integrity and gastric protection, while NSAIDs can cause mucosal irritation and lead to ulceration. This combined effect can overwhelm protective mechanisms in the gastrointestinal tract and result in serious bleeding.
Increased likelihood of gastrointestinal bleeding, which may lead to hospitalization or emergency interventions.
Regularly assess the patient's need for both SSRIs and NSAIDs, and consider alternative pain management strategies or add a gastroprotective agent if both medications are essential.
Was this helpful?
The content on SafeTo is for informational purposes only and does not constitute medical, veterinary, or professional advice. Always consult with a qualified professional for specific concerns.
